Blog
RSS FeedPosted by Michael Wonder on 24 Nov 2016
Updated submission form and guide for Patient Group Partners
24 November 2016 - Following feedback from patient groups and our committee members, the SMC has introduced an updated Patient ...
Posted by Michael Wonder on 13 Nov 2016
SMC - November 2016 decisions
7 November 2016 - Five new medicines accepted for routine use in Scotland. ...
Posted by Michael Wonder on 11 Oct 2016
People with an advanced form of thyroid cancer now able to benefit from Lenvima (lenvatinib mesylate) in Scotland
10 October 2016 - Patients in England denied access to lenvatinib mesylate due to administrative delays. ...
Posted by Michael Wonder on 10 Oct 2016
Life-extending lung cancer drug approved for use in Scotland
10 October 2016 - Scotland has become the first part of the UK to approve a new life-extending treatment for ...
Posted by Michael Wonder on 10 Oct 2016
SMC - October 2016 decisions
10 October 2016 - New treatments for thyroid cancer and lung cancer among five medicines accepted for routine use by ...
Posted by Michael Wonder on 09 Oct 2016
Leading rheumatologist appointed new chair of SMC
7 October 2016 - One of Scotland’s leading rheumatologists has been appointed as the next chair of the SMC. ...
Posted by Michael Wonder on 14 Sep 2016
SMC introductory industry engagement event - September 2016
13 September 2016 - This event is designed to help pharmaceutical industry members who require an understanding of the processes for ...
Posted by Michael Wonder on 13 Sep 2016
Updated SMC guidance on comparator medicines with a patient access scheme
12 September 2016 - The SMC’s guidance to manufacturers about comparator medicines accepted for use on the basis of a confidential ...
Posted by Michael Wonder on 12 Sep 2016
Blood cancer drug approved for use on Scottish NHS
12 September 2016 - Scottish patients with a rare form of blood cancer have been granted access to a daily pill ...
Posted by Michael Wonder on 12 Sep 2016
SMC - September 2016 decisions
12 September 2016 - Three new medicines accepted for routine use by NHS Scotland. ...
Posted by Michael Wonder on 08 Aug 2016
SMC - August 2016 decisions
8 August 2016 - Treatments for blood cancer, skin cancer and high cholesterol among six new medicines accepted for routine use ...
Posted by Michael Wonder on 02 Aug 2016
Call for NHS to haggle with drug companies over price of new treatments
1 August 2016 - Opposition politicians are calling for the Scottish NHS to haggle with drug companies over the price of ...
Posted by Michael Wonder on 18 Jul 2016
Diabetes drugs cost the NHS in Scotland almost £90 million last year
16 July 2016 - Diabetes drugs cost the NHS in Scotland almost £90 million last year amid fears that public health ...
Posted by Michael Wonder on 11 Jul 2016
SMC gives green light for BMS’ Opdivo
11 July 2016 - Scotland will be first UK country to access the drug after NICE refusal. ...
Posted by Michael Wonder on 11 Jul 2016
SMC - July 2016 decisions
11 July 2016 - Two new medicines for lung cancer among five treatments accepted for routine use in NHS Scotland. ...